Targeting GPCRs to treat and prevent dementia [ 2017 - ]

Research Grant

Researchers: Dr Daniel Scott (Principal investigator)

Brief description Alzheimer’s disease (AD), is the most common form of dementia, accounting for between 50-70% of all cases. There is general agreement that current treatments for AD/dementia are inadequate so new treatment strategies are desperately needed. I am addressing these challenges by developing new technologies to generate next generation treatments for AD.

Funding Amount $720,451.00

Funding Scheme Boosting Dementia Research Initiative

Notes Boosting Dementia Research Leadership Fellowship